HCC1806

The HCC1806 cell line is derived from the mammary gland of a 60-year-old patient with acantholytic squamous cell carcinoma. These cells lack receptors for estrogen and progesterone, and the absence of epidermal growth factor receptor (EGFR) amplification, categorize it as a triple-negative breast cancer. The cell line is instrumental for the biological validation of therapeutic targets, as it closely mirrors the behavior of TNBC in vivo, including tendencies for spontaneous metastasis and resistance to conventional therapies like paclitaxel.

Molecular effects of interventions, such as AEB071 treatment, on HCC1806 cells, provide insights into the cell proliferation pathways and the potential of protein kinase inhibitors as therapeutic agents. The use of HCC1806 in xenograft models contributes to the study of tumor growth and metastasis in a controlled environment.

HCC1806 breast cancer cells serve as a valuable tool for the study of breast cancer, particularly within the context of triple-negative subtypes. It stands as a critical resource for researchers looking to unravel the molecular interactions in breast cancer and search for effective treatments against this challenging variant of the disease.

37°C, 5% CO₂, humidified atmosphere.

1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

At Cytion, we stand behind the quality and viability of our products. We guarantee that our cells will be viable at the start of culture for 60 days after shipment from our facilities. We assure that all materials conform to the specifications described in the Certificate of Analysis and/or Product Sheet.

For full details, please refer to our Warranty Statement.